SCHEMBL5589338

SCHEMBL5589338

Oc1cc2c(c(CCBr)c1O)Oc1ccccc1O2

nearest known ligand 0.33

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
AHR P35869 4/20 0.33
MAOA P21397 1/20 0.31
MAOB P27338 1/20 0.31
TOP1 P11387 1/20 0.31
TOP2A P11388 1/20 0.31
ALOX15 P16050 1/20 0.30
ALOX12 P18054 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5587842 0.91 AHR (0.32) AHR
SCHEMBL5587757 0.90 AHR (0.31) AHR
SCHEMBL5590367 0.87 AHR (0.35) AHRMAOAMAOBTOP1TOP2A
SCHEMBL5589266 0.85 AHR (0.32) AHR
SCHEMBL5590239 0.84 KDM4E (0.37) AHR
SCHEMBL5588336 0.84 AHR (0.36) AHRMAOAMAOBTOP1TOP2A
SCHEMBL5587822 0.84 AHR (0.31) AHR
SCHEMBL5587558 0.82 AHR (0.30) AHR
SCHEMBL5589303 0.82 AHR (0.34) AHR
SCHEMBL5590489 0.82 CYP1A1 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 AHR 1434/4885MAOA 242/4885MAOB 359/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.